Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16:22:eAO0563.
doi: 10.31744/einstein_journal/2024AO0563. eCollection 2024.

Use of convalescent plasma in COVID-19 treatment: is clinical severity more important than the intervention?

Valéria de Freitas Dutra  1 , Heitor Duarte de Andrade  1 , Viviane Regina Hernandez Nunes  1 , Gabriella Mafra Elia  1 , Juliane Roberta Dias Torres  1 , Carolina Bonet Bub  1 , Ana Paula Hitomi Yokoyama  1 , José Mauro Kutner  1
Affiliations

Use of convalescent plasma in COVID-19 treatment: is clinical severity more important than the intervention?

Valéria de Freitas Dutra et al. Einstein (Sao Paulo). .

Abstract

Objective: This study compared the outcomes of two cohorts of patients with coronavirus disease 2019 (COVID-19) who received COVID-19 convalescent plasma transfusions between 2020 and 2021.

Methods: This retrospective study was conducted at a tertiary hospital in São Paulo, Brazil. We included a retrospective cohort of patients who received convalescent compassionate plasma, and another group of patients from a previous clinical study. We collected clinical and laboratory data on the day of and 5 days after transfusion. Patients with hematological or immunological conditions were excluded. Statistical significance was set at p<0.05.

Results: COVID-19 convalescent plasma did not affect the outcomes of patients with severe COVID-19 when comparing the two cohorts transfused with different volumes and titers of neutralizing antibodies. Despite improvements in some laboratory parameters, no effect on clinical outcomes was observed. Dialysis negatively affected the length of intensive care unit stay, hospitalization, and mechanical ventilation use. Each higher point on the day 0 World Health Organization scale reduced the probability of hospital and intensive care unit discharge and the risk of mechanical ventilation discontinuation.

Conclusion: Dialysis and the assessed clinical severity represented by the World Health Organization scale on day 0 influenced the outcomes, whereas COVID-19 convalescent plasma transfusion did not.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2004;2(9):695–703. - PubMed
    1. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117(17):9490–9496. - PMC - PubMed
    1. Whitfield K, Huemer KH, Winter D, Thirstrup S, Libersa C, Barraud B, et al. Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries. Trials. 2010;11(1):104–104. - PMC - PubMed
    1. Rubin R. Once Viewed as a Promising COVID-19 treatment, convalescent plasma falls out of favor. JAMA. 2022;327(12):1115–1116. - PubMed
    1. Estcourt LJ, Cohn CS, Pagano MB, Iannizzi C, Kreuzberger N, Skoetz N, et al. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma. Ann Intern Med. 2022;175(9):1310–1321. - PMC - PubMed

MeSH terms